Literature DB >> 3865219

Evolution of apolipoprotein E: mouse sequence and evidence for an 11-nucleotide ancestral unit.

T B Rajavashisth, J S Kaptein, K L Reue, A J Lusis.   

Abstract

Apolipoprotein E (apo E) is responsible for the binding of very low density lipoprotein and chylomicron remnants to cellular receptors thereby removing them from circulation. We have isolated and determined the sequence of a cDNA encoding 285 amino acids and the entire 3' untranslated region of 112 nucleotides of mouse apo E. The remaining coding sequence was determined by sequencing mouse liver mRNA. Comparisons with rat and human apo E sequences showed a high degree of conservation although there were regions in each species that were characterized by unique insertions and deletions. Analysis of the sequence homologies within apo E revealed that the entire sequence is made up of repetitive units. The most primitive unit appeared to be an 11-nucleotide repeat within higher order repeats of 22 or 33 nucleotides. The 11-nucleotide unit -TCGGACGAGGC- is read in all three reading frames, and when tandemly repeated, it encodes the highly conserved amino acid sequence Xaa-(Glu/Asp)-(Glu/Asp)-Xaa-Arg-Xaa-Arg-Leu-Gly-Xaa-Xaa. We postulate that apo E and those other apolipoproteins related to it have arisen by duplications and subsequent modifications of this or a closely related 11-nucleotide ancestral sequence.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3865219      PMCID: PMC391447          DOI: 10.1073/pnas.82.23.8085

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  28 in total

1.  Repeated helical pattern in apolipoprotein-A-I.

Authors:  A D McLachlan
Journal:  Nature       Date:  1977-06-02       Impact factor: 49.962

2.  Enhanced binding by cultured human fibroblasts of apo-E-containing lipoproteins as compared with low density lipoproteins.

Authors:  T L Innerarity; R W Mahley
Journal:  Biochemistry       Date:  1978-04-18       Impact factor: 3.162

3.  Phylogenies constrained by the crossover process as illustrated by human hemoglobins and a thirteen-cycle, eleven-amino-acid repeat in human apolipoprotein A-I.

Authors:  W M Fitch
Journal:  Genetics       Date:  1977-07       Impact factor: 4.562

4.  A new method for sequencing DNA.

Authors:  A M Maxam; W Gilbert
Journal:  Proc Natl Acad Sci U S A       Date:  1977-02       Impact factor: 11.205

Review 5.  Empirical predictions of protein conformation.

Authors:  P Y Chou; G D Fasman
Journal:  Annu Rev Biochem       Date:  1978       Impact factor: 23.643

6.  Heterogeneity of human plasma very low density lipoproteins. Separation of species differing in protein components.

Authors:  V G Shore; B Shore
Journal:  Biochemistry       Date:  1973-01-30       Impact factor: 3.162

7.  Computer analysis of nucleic acids and proteins.

Authors:  C L Queen; L J Korn
Journal:  Methods Enzymol       Date:  1980       Impact factor: 1.600

8.  3' non-coding region sequences in eukaryotic messenger RNA.

Authors:  N J Proudfoot; G G Brownlee
Journal:  Nature       Date:  1976-09-16       Impact factor: 49.962

9.  Evolution of lipoproteins deduced from protein sequence data.

Authors:  W C Barker; M O Dayhoff
Journal:  Comp Biochem Physiol B       Date:  1977

10.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

View more
  23 in total

1.  Plasma lipoprotein metabolism in transgenic mice overexpressing apolipoprotein E. Accelerated clearance of lipoproteins containing apolipoprotein B.

Authors:  H Shimano; N Yamada; M Katsuki; K Yamamoto; T Gotoda; K Harada; M Shimada; Y Yazaki
Journal:  J Clin Invest       Date:  1992-11       Impact factor: 14.808

2.  Amyloid A protein amyloidosis induced in apolipoprotein-E-deficient mice.

Authors:  Y Hoshii; H Kawano; D Cui; T Takeda; T Gondo; M Takahashi; K Kogishi; K Higuchi; T Ishihara
Journal:  Am J Pathol       Date:  1997-10       Impact factor: 4.307

3.  Neuropathological changes in scrapie and Alzheimer's disease are associated with increased expression of apolipoprotein E and cathepsin D in astrocytes.

Authors:  J F Diedrich; H Minnigan; R I Carp; J N Whitaker; R Race; W Frey; A T Haase
Journal:  J Virol       Date:  1991-09       Impact factor: 5.103

4.  Primary structure of guinea pig apolipoprotein E.

Authors:  T Matsushima; G S Getz; S C Meredith
Journal:  Nucleic Acids Res       Date:  1990-01-11       Impact factor: 16.971

5.  Generation of mice carrying a mutant apolipoprotein E gene inactivated by gene targeting in embryonic stem cells.

Authors:  J A Piedrahita; S H Zhang; J R Hagaman; P M Oliver; N Maeda
Journal:  Proc Natl Acad Sci U S A       Date:  1992-05-15       Impact factor: 11.205

6.  Mouse apolipoprotein A-IV gene: nucleotide sequence and induction by a high-lipid diet.

Authors:  S C Williams; S M Bruckheimer; A J Lusis; R C LeBoeuf; A J Kinniburgh
Journal:  Mol Cell Biol       Date:  1986-11       Impact factor: 4.272

7.  Overexpression of apolipoprotein E in transgenic mice: marked reduction in plasma lipoproteins except high density lipoprotein and resistance against diet-induced hypercholesterolemia.

Authors:  H Shimano; N Yamada; M Katsuki; M Shimada; T Gotoda; K Harada; T Murase; C Fukazawa; F Takaku; Y Yazaki
Journal:  Proc Natl Acad Sci U S A       Date:  1992-03-01       Impact factor: 11.205

8.  Apolipoprotein E4 and beta amyloid in senile plaques and cerebral blood vessels of aged rhesus monkeys.

Authors:  A Poduri; M Gearing; G W Rebeck; S S Mirra; J Tigges; B T Hyman
Journal:  Am J Pathol       Date:  1994-06       Impact factor: 4.307

9.  Cloning and sequencing of bovine apolipoprotein E complementary DNA and molecular evolution of apolipoproteins E, C-I, and C-II.

Authors:  Y W Yang; L Chan; W H Li
Journal:  J Mol Evol       Date:  1991-06       Impact factor: 2.395

10.  Overproduction of cholesterol and fatty acids causes massive liver enlargement in transgenic mice expressing truncated SREBP-1a.

Authors:  H Shimano; J D Horton; R E Hammer; I Shimomura; M S Brown; J L Goldstein
Journal:  J Clin Invest       Date:  1996-10-01       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.